FREE Breaking News Alerts from StreetInsider.com!
E-mail Address
Top NewsMost Read Highlighted
Get AlertsCMRX Hot Sheet
Chimerix, Inc. (Nasdaq: CMRX) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering price is $85 million. Chimerix plans to list on the Nasdaq Global Market under the ticker “CMRX.”
The offering is being made through Morgan Stanley, Cowen, William Blair, and Lazard Capital.
Chimerix is a biopharmaceutical company committed to the discovery, development and commercialization of novel, oral antiviral therapeutics that are designed to transform patient care in areas of high unmet medical need.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items – JOIN NOW